knowledge -WSS

knowledge

author：leisure time 2025-10-02 09:47:15 - browse：2

Illumina, the leading maker of DNA sequencing machines, said Sunday that it would divest Grail, the developer of a multi-cancer screening test, which it bought over the objections of regulators in the U.S. and Europe in August 2021.

Illumina said the decision to spin Grail off followed a Friday decision of the U.S. Fifth Circuit Court of Appeals, which held that the merger was anti-competitive. It said that it would divest Grail either by selling it to another company or listing it on capital markets, consistent with an order from the European Commission, and that it aims to finalize the terms of the deal by the end of the second quarter of 2024.

The decision opens what should be the final chapter in one of the most disastrous attempted mergers in biotech history. Illumina, a storied name that had delivered investors strong returns over two decades, spun out Grail in 2016 in order to raise money to fund the company’s work. Then, it announced plans to re-acquire the firm for $7.1 billion in Sept. 2020.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Hospital at home shows how to bring innovation to health care

knowledge

WSS

Vivek Ramaswamy made waves in the debate, much as in biotech

A double vaccine crisis is endangering millions of children

How artificial intelligence is being used to detect, treat cancer

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Caitlin Bernard's story shows physicians can't shy from advocacy

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

focus

knowledge

explore

Novavax promises a turnaround & Lilly roils the obesity market

CDC says it’s too soon to assess risk posed by Covid subvariant

Jerome Adams on the need for new antivirals for Covid

HIPAA doesn't protect reproductive records from prosecutors

Peter Hotez and the public health issue of online harassment

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

How to save PrEP access — and even expand it

Abortion policy in the spotlight at Republican debate

Hepatitis C has a cure — but many Americans still lack access to it

Court strikes down limits on filming of police in Arizona

knowledge

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

FDA advisory panel to debate high blood pressure devices

Can U.S. cancer drug shortages be fixed?

7 of the most gruesome medical devices in history

Kellogg’s is going to war over Mexico’s nutrition label rules

CDC backtracks, saying fully vaccinated people can go maskless indoors

explore

leisure time

knowledge

entertainment